ALKERMES

Details for Australian Trade Mark No. 1378679 (hide)

Owner Alkermes, Inc.

Convention US 4 March 2010 77/950318

Service Davies Collison Cave

Various Convention priority claimed: 4 March 2010, United States of America, No. 77/950318 in respect of PHARMACEUTICAL PREPARATIONS AND COMPOUNDS, NAMELY, SMALL MOLECULES AND CHEMICAL COMPOUNDS FOR USE IN OPIOID MODULATION; PHARMACEUTICAL PREPARATIONS AND COMPOU

Filing Date 19 August 2010

Classes

Class 1 Protein fusion compounds, pro drugs and small molecule compounds for scientific and medical research

Class 5 Pharmaceutical preparations and compounds, including, small molecules and chemical compounds for use in opioid modulations; pharmaceutical preparations and compounds for use in treating addiction, substance abuse and dependence, all disorders, CNS disorders, pain and constipation; pharmaceutical compunds including protein fusion compounds for medical use including as drug delivery agents; fusion compounds for the delivery pharmaceutical; pro drugs for medical use including anti-psychotic for use in treating CNS disorders

Event Publications

9 September 2010 Application filed

28 April 2011 Application Accepted

11 August 2011 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1378680-Shiploads

1378678